You are here

Encourage Adherence

Medication adherence is a concern with all therapies but is particularly important with medications prescribed for chronic conditions,¹ such as cardiovascular disease (CVD). Dosing complexity can affect medication adherence for many patients, particularly the elderly and those with co-morbid conditions.²

Nonadherence to medication regimens can lead to unsatisfactory outcomes. For patients who have been diagnosed with atrial fibrillation (AF) or who have had a venous thromboembolism (VTE), medication nonadherence can lead to recurrent VTE and stroke or systemic embolism, respectively.^3,4

The resources below highlight study results and insights into treatment, dosing frequency in patients with CVD, and other factors that may encourage medication adherence in your patients with CVD.

9 resources available

Adherence Rates Consistently Higher for Once-Daily Versus Twice-Daily Dosing

Study results show medication adherence was inversely related to the number of prescribed doses per day, and that once-daily dosing is easier for patients and results in fewer dosing mistakes or missed doses.

View Resource

Adherence Rates Consistently Higher for Once-Daily Versus Twice-Daily Dosing

View Resource

AF Care Coordination Checklist

Step-by-step checklist for review when considering transitioning patients from one site of care to the next, to help ensure that appropriate information is shared among healthcare professionals, patients, and their caregivers.

View Resource

Complexities of Warfarin Therapy Lead to Increased Resource Utilization

Reviews the drug and food interactions, fluctuations in international normalized ratio (INR) levels, and other attributes of warfarin use, including the possibility of hospitalizations that can lead to increased cost of care for patients.

View Resource

Get the Facts on AF

Patient-oriented information about AF, including symptoms, stroke risk, and tips for working with their healthcare team.

View Resource

Management of AF-related Stroke

Facts about stroke risk in patients with AF, and a synopsis of guidelines for thromboprophylaxis.

View Resource

Managing VTE Risk in Knee and Hip Replacement

Overview of VTE risk-reduction strategies at each stage of a knee or hip replacement procedure—from preoperative planning through the postdischarge period.

View Resource

Prescribing Treatment Is Only the First Step—Patient Adherence Drives Outcomes

Presents the reasons why patients discontinue or are not-adherent with warfarin.

View Resource

Unstable INR Has Implications for Healthcare Resource Use

Reviews the health implications and risks for patients with DVT and/or PE or AF who fall out of INR range as well as resource use and associated costs.

View Resource

Get Adobe Reader

Janssen tools and resources have not been proven to improve outcomes and may not completely address the specific intervention activities listed on each page. Janssen tools or resources discussed should be evaluated against other available sources of information before decisions are made about how to approach patient care within your organization. Full descriptions of appropriate use and associated limitations are set forth in the respective tools and resources.

This information has been developed by Janssen Pharmaceuticals, Inc., and made widely available to support patient and provider education.

References:

Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304-314.
Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028-3035.
Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica. 2007;92(2):199-205.
Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GYH. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med. 2010;123(7):638-645.